Table 1.
Type of Nanocarrier | Nanocarrier Composition |
Therapeutics | Microfluidic Device Type | Potential Application |
Ref. |
---|---|---|---|---|---|
Liposome | PC and CHOL | Propofol | SHM * | Anesthesia | [68] |
PC, DMPC, DPPC, CHOL, PS, and DSPC | Insulin, BSA, or OVA | SHM * | - | [69] | |
HSPC, CHOL, and DSPE-PEG2000 | DOX | N/A * | Cancer: MDA-MB231cells and xenograft model bearing MDA-MB231tumor | [82] | |
PC, DMPC, DPPC, and DSPC | Glipizide and metformin | SHM * | Diabetes | [83] | |
DMPC, DPPC, and DSPC | Cisplatin and Curcumin | SHM * | Cancer: EMT6 and B16F10 cells/and xenograft model bearing EMT6 and B16F10 tumor | [84] | |
DSPC, CHOL, and DSPE-PEG2000 | DOX and UMB | 5-Input Chip ** | Cancer: MCF-7, MDA-MB231, and BT-473 cells | [85] | |
DMPC, DSPE-PEG, and CHOL. Ligands: DSPE-PEG-TAT and DSPE-PEG-Folate | - | HFF device | Cancer: SKOV3 and MCF-7 cells and 3D tumor spheroids/and xenograft model bearing SKOV3 tumor | [86] | |
Lipoplexes | cationic lipid DOTAP, EPC, and DOPE | pEGFP-N1 | HFF device | PC3 cells | [87,88] |
cationic lipid (DOTAP, DDA, DC-CHOL, DMTAP, DSTAP or DOBAQ), DOPE or DSPC, CHOL, and DMG-PEG2000 | SAM encoding rabies virus glycoprotein (RVG) | Y-shape SHM * | Prophylactic vaccine:BHK cells and BALB/c mice | [72] | |
cationic lipid DOTAP, DC-CHOL, DOPE, CHOL, and DOPE-PEG | pGL3 | Y-shape SHM * | HEK-293, HaCaT, N/TERT, and CaSki cells | [89] | |
pH-sensitive cationic lipid YSK05, chol, and PEG-DMG | siFVII | Baffle mixer device | ICR mice liver tissues: hepatocytes delivery and FVII gene-silencing activity. | [90] | |
iLNP and cLNP | Ionizable lipid MC3 or cationic lipids DOTAP and DDAB, HSPC or DSPC, CHOL, and DMG-PEG2000 or DSPE-PEG2000 | PolyA, ssDNA or mFLuc | Y-shape SHM * | N/A | [70] |
Ionizable lipid (MC3, KC2, DODMA) or cationic lipid (DOBAQ, DOTMA, DOTAP), DSPC, DMG-PEG2k, and CHOL | mRNAs: mFLuc, mEGFP, and mCherry | N/A | Retinal degeneration: BALB/c mice | [91] | |
iLNP | Ionizable lipid (C12−200), DOPE or DSPC, CHOL, and lipid-PEG | siFVII or mLuc | SHM parallelized device | HeLa cells and C57BL/6 mice | [21] |
Ionizable lipids MC3 or KC2, DLinDAP or DLinDMA, CHOL, DOPE, DOPC, SOPC, DLinPC, DPoPC or DSPC, and DMG-PEG | pDNAs: pEGFP or pFLuc | T-junction mixer | HeLa, HepG2, Hep3B, PC12, and MCF7 cells (in vitro) and leghorn chicken embryos (in vivo) | [92] | |
ATX ionizable amino lipids, CHOL, DSPC, and DMG-PEG | pWRG/c7d11 | N/A* | Prophylactic Andes and Zika virus vaccine: Vero cells, rabbits, and nonhuman primates | [93] | |
Ionizable lipid KC2, CHOL, DSPC, and DMG-PEG | mFLuc or mcDNA | T-junction mixer | N/A | [94] |
* NanoAssemblr Benchtop ™ (Precision Nanosystems, Vancouver, BC, Canada). ** Automated Dolomite microfluidic system (Dolomite, Royston, UK).